Caribou Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Stock Information for Nxu Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Nxu Inc.

Caribou Biosciences to Participate in the Jefferies Global Healthcare Conference
Caribou Biosciences Reports First Quarter 2025 Financial Results and Provides Business Update
Caribou Biosciences to Participate in the BofA Securities 2025 Health Care Conference
Caribou Biosciences Announces Strategic Pipeline Prioritization with Focus on CB-010 and CB-011 Oncology Programs
CARIBOU ALERT: Bragar Eagel & Squire, P.C. is Investigating Caribou Biosciences, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
CRBU Deadline: CRBU Investors Have Opportunity to Lead Caribou Biosciences, Inc. Securities Fraud Lawsuit
Caribou Biosciences, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses; February 24, 2025 Deadline to file Lead Plaintiff Motion
CRBU DEADLINE TODAY: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Caribou Biosciences, Inc. Investors to Secure Counsel Before Important February 24 Deadline in Securities Class Action - CRBU

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.